{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Anton Iliuk"}, {"accession": "MS:1000589", "name": "contact email", "value": "ailiuk@purdue.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Purdue University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Andy Tao"}, {"accession": "MS:1000589", "name": "contact email", "value": "watao@purdue.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Purdue University"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-EVtrap-phosphoproteome.raw"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-EVtrap-phosphoproteomics.mzTab"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/022720-plasma-EV-Veravas-EVtrap-phos-1.mzML"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/022720-plasma-EV-Veravas-EVtrap-prot-1.mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-EVtrap-proteomics.mzTab"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-EVtrap-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-100K-UC-proteome.raw"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/022020-plasma-EV-100K-prot.mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-100K-UC-proteomics.mzTab"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/022020-plasma-EV-100K-phos-2mL.mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-100K-UC-phosphoproteomics.mzTab"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-100K-UC-phosphoproteome.raw"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/022020-plasma-EV-100K-Veravas-EVtrap-1-prot-quant.mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-100K-UC-and-EVtrap-proteomics-quant.mzid"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/022020-plasma-EV-100K-Veravas-EVtrap-phos-quant-only-two.mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-100K-UC-and-EVtrap-phosphoproteomics-quant.mzid"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient1-control-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient10-CKD-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient11-RCC-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient12-RCC-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient13-RCC-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient14-RCC-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient15-RCC-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient2-control-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient3-control-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient4-control-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient5-control-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient6-CKD-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient7-CKD-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient8-CKD-proteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient9-CKD-proteome.raw"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/112019-plasma-veravas-kidney-clinical-fullproteome-quant-grouped-(2).mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-proteomics-control-CKD-RCC-quant.mzTab"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient1-control-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient10-CKD-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient11-RCC-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient12-RCC-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient13-RCC-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient14-RCC-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient15-RCC-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient2-control-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient3-control-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient4-control-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient5-control-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient6-CKD-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient7-CKD-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient8-CKD-phosphoproteome.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-clinical-patient9-CKD-phosphoproteome.raw"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/112019-plasma-veravas-kidney-clinical-phosphoproteome-quant-grouped.mzML"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994/Plasma-EV-phosphoproteomics-control-CKD-RCC-quant.mzTab"}], "description": "Invasive nature and pain caused to patients inhibit the routine use of tissue biopsy-based procedures for cancer diagnosis and surveillance. The analysis of extracellular vesicles (EVs) from biofluids have recently gained significant traction in the liquid biopsy field. EVs offer an essential \u201csnapshot\u201d of their precursor cells in real time and contain information-rich collection of nucleic acids, proteins, lipids, etc. The analysis of protein phosphorylation, as a direct marker of cellular signaling and disease progression, could be an important stepstone to successful liquid biopsy applications. Here, we introduce a rapid EV isolation method based on chemical affinity called EVtrap (Extracellular Vesicles Total Recovery and Purification) for EV phosphoproteomics analysis of human plasma. Incorporating EVtrap with high performance mass spectrometry (MS), we were able to identify over 16,000 unique peptides representing 2,238 unique EV proteins from just 5 \u03bcL plasma sample, including most known EV markers, with substantially higher recovery levels compared to ultracentrifugation. Most importantly, more than 5,500 unique phosphopeptides representing almost 1,600 phosphoproteins in EVs were identified using only 1 mL of plasma. Finally, we carried out quantitative EV phosphoproteomics analysis of plasma samples from patients diagnosed with chronic kidney disease or kidney cancer (RCC), identifying dozens of phosphoproteins capable of distinguishing disease states from healthy controls. The study demonstrates the potential feasibility of our robust analytical pipeline for cancer signaling monitoring by tracking plasma EV phosphorylation.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD017994"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD017994"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD017994"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "EVtrap, exosomes, phosphoproteomics, kidney cancer"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "32396726"}, {"accession": "MS:1002866", "name": "Reference", "value": "Iliuk A, Wu X, Li L, Sun J, Hadisurya M, Boris RS, Tao WA. Plasma-Derived Extracellular Vesicle Phosphoproteomics through Chemical Affinity Purification. J Proteome Res. 2020"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Plasma-derived EV Phosphoproteomics through Chemical Affinity Purification"}